AARTI PHARMALABS
Back to All Ratios
|
AARTI PHARMALABS Last 5 Year EBIT Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EBIT Growth(%) | 12.73 | 68.42 | - | - |
What is the latest EBIT Growth ratio of AARTI PHARMALABS ?
Year | EBIT Growth |
---|---|
Mar2024 | 12.73 |
Mar2023 | 68.42 |
Mar2022 | - |
Mar2021 | - |
How is EBIT Growth of AARTI PHARMALABS Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2024 | 12.73 | -81.39 | |
Mar2023 | 68.42 | 0 | |
Mar2022 | 0 | 0 | |
Mar2021 | 0 | - |
Other Financial Ratios of AARTI PHARMALABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,940.2 Cr | -0.1% | 11.4% | 51.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -0.1% |
11.4% |
51.6% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses